Enormous pain/ soreness; The injection site is red; The injection site is hot; The skin is hard and it is tight; Flu symptoms; Low energy; Headache; Really tired; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Enormous pain/ soreness), VACCINATION SITE ERYTHEMA (The injection site is red), VACCINATION SITE WARMTH (The injection site is hot), SKIN TIGHTNESS (The skin is hard and it is tight) and INFLUENZA LIKE ILLNESS (Flu symptoms) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LOSARTAN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Enormous pain/ soreness), VACCINATION SITE ERYTHEMA (The injection site is red), VACCINATION SITE WARMTH (The injection site is hot), SKIN TIGHTNESS (The skin is hard and it is tight), INFLUENZA LIKE ILLNESS (Flu symptoms), ASTHENIA (Low energy), HEADACHE (Headache) and FATIGUE (Really tired). At the time of the report, PAIN IN EXTREMITY (Enormous pain/ soreness), VACCINATION SITE ERYTHEMA (The injection site is red), VACCINATION SITE WARMTH (The injection site is hot), SKIN TIGHTNESS (The skin is hard and it is tight), INFLUENZA LIKE ILLNESS (Flu symptoms), ASTHENIA (Low energy), HEADACHE (Headache) and FATIGUE (Really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient contacted her doctor regarding events and patient was told to apply ice and to keep an eye on it.  Patient received treatment including Advil, extra strength cortisone cream and ice.   No concomitant medication was reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 22-Jan-2021.    This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Enormous pain/ soreness), VACCINATION SITE ERYTHEMA (The injection site is red), VACCINATION SITE WARMTH (The injection site is hot), SKIN TIGHTNESS (The skin is hard and it is tight) and INFLUENZA LIKE ILLNESS (Flu symptoms) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LOSARTAN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Enormous pain/ soreness), VACCINATION SITE ERYTHEMA (The injection site is red), VACCINATION SITE WARMTH (The injection site is hot), SKIN TIGHTNESS (The skin is hard and it is tight), INFLUENZA LIKE ILLNESS (Flu symptoms), ASTHENIA (Low energy), HEADACHE (Headache) and FATIGUE (Really tired). At the time of the report, PAIN IN EXTREMITY (Enormous pain/ soreness), VACCINATION SITE ERYTHEMA (The injection site is red), VACCINATION SITE WARMTH (The injection site is hot), SKIN TIGHTNESS (The skin is hard and it is tight), INFLUENZA LIKE ILLNESS (Flu symptoms), ASTHENIA (Low energy), HEADACHE (Headache) and FATIGUE (Really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient contacted her doctor regarding events and patient was told to apply ice and to keep an eye on it.  Patient received treatment including Advil, extra strength cortisone cream and ice.   No concomitant medication was reported.